Response inhibition in Huntington's disease-A study using ERPs and sLORETA

Neuropsychologia

Volumn 46, Issue 5, 2008, Pages 1290-1297

  Beste, Christian ^a,b,c   Saft, Carsten ^a   Andrich, Jürgen ^a   Gold, Ralf ^a   Falkenstein, Michael ^b  

^a Chirurgische Klinik   (Germany)

^b LEIBNIZ RESEARCH CENTRE FOR WORKING ENVIRONMENT AND HUMAN FACTORS   (Germany)

^c UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

Basal ganglia; Dopamine; Genetics; Nogo N2; Nogo P3; sLORETA

Indexed keywords

ADULT; ARTICLE; ATTENUATION; BRAIN DYSFUNCTION; BRAIN ELECTRICAL TOMOGRAPHY; BRAIN FUNCTION; BRAIN NERVE CELL; BRAIN REGION; BRAIN TOMOGRAPHY; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; EVENT RELATED POTENTIAL; FRONTAL CORTEX; GENETIC DISORDER; HUMAN; HUNTINGTON CHOREA; INHIBITION (PSYCHOLOGY); PREFRONTAL CORTEX; TASK PERFORMANCE;

ADULT; DATA INTERPRETATION, STATISTICAL; ELECTROENCEPHALOGRAPHY; ELECTROPHYSIOLOGY; EVOKED POTENTIALS; FEMALE; HUMANS; HUNTINGTON DISEASE; INHIBITION (PSYCHOLOGY); MALE; MIDDLE AGED; PHOTIC STIMULATION; PSYCHOMOTOR PERFORMANCE; REACTION TIME; TOMOGRAPHY;

EID: 42749083644     PISSN: 00283932     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropsychologia.2007.12.008     Document Type: Article

References (71)

1. Antonini A., Leenders K.L., and Eidelberg D. [11C]raclopride-PET studies of the Huntington's disease rate of progression: Relevance of the trinucleotide repeat length. Annals of Neurology 43 (1998) 253-255
2. Aron A.R., Schlaghecken F., Fletcher P.C., Bullmore E.T., Eimer M., Barker R., et al. Inhibition of subliminally primed response is mediated by the caudate and thalamus: Evidence from functional MRI and Huntington's disease. Brain 126 (2003) 713-723
3. Aylward E.H., Sparks B.F., Field K.M., Yallapragada V., Shpritz B.D., Rosenblatt A., et al. Onset and rate of striatal atrophy in preclinical Huntington's disease. Neurology 63 (2004) 66-72
4. Band G.P., and van Boxtel G.J. Inhibitory motor control in stop paradigms: Review and reinterpretation of neural mechanisms. Acta Psycholgica-Amsterdam 101 (1999) 179-211
5. Barcelo F. The Madrid card sorting test (MCST): A task switching paradigm to study executive attention with event-related potentials. Brain Research Brain Research Protocols 11 (2003) 27-37
6. Bartenstein P., Weindl A., Spiegel S., Boecker H., Wenzel R., Ceballos-Baumann A.O., et al. Central motor processing in Huntington's disease. A PET study. Brain 120 (1997) 1553-1567
7. Bekker E.M., Kenemans J.L., Hoeksama M.R., Talsma D., and Verbaten M.N. Source analysis of the N2 in a cued Go/NoGo task. Brain Research Cognitive Brain Research 22 (2005) 221-231
8. Beste C., Saft C., Andrich J., Gold R., and Falkenstein M. Error processing in Huntington's disease. PLoS ONE (2006) e86
9. Beste C., Saft C., Konrad C., Andrich J., Habbel A., Schepers I., et al. Levels of error processing in Huntington's disease: A combined study using event-related potentials and voxel-based morphometry. Human Brain Mapping (2007) [Epub ahead of print]
10. Bokura H., Yamaguchi S., and Kobayashi S. Electrophysiological correlates for responses inhibition in a Go/Nogo task. Clinical Neurophysiology 112 (2001) 2224-2232
11. Bokura H., Yamahuchi S., and Kobayashi S. Event-related potentials for response inhibition in Parkinson's disease. Neuropsychologia 43 (2005) 967-975
12. Braver T.S., Barch D.M., Gray J.R., Molfese D.L., and Snyder A. Anterior cingulated cortex and response conflict: Effects of frequency, inhibition and errors. Cerebral Cortex 11 (2001) 825-836
13. Bruin K.J., Wijers A.A., and van Staveren A.S. Response priming in a Go/Nogo task: Do we have to explain the Go/Nogo N2 effects in terms of response activation instead of inhibition?. Clinical Neurophysiology 112 (2001) 1660-1671
14. Burle B., Vidal F., Tandonnet C., and Hasbroucq T. Physiological evidence for response inhibition in choice reaction time tasks. Brain and Cognition 56 (2004) 153-164
15. Cabeza R., and Nyberg L. Imaging cognition II: An empirical review of 275 PET and fMRI studies. Journal of Cognitive Neuroscience 12 (2000) 1-47
16. Chudasama Y., and Robbins T.W. Functions of frontostriatal systems in cognition: Comparative neuropsychopharmacological studies in rats, monkeys and humans. Biological Psychology 73 (2006) 19-38
17. Craufurd D., and Snoden J. Neuropsychological and neuropsychiatric aspects of Huntington's disease. In: Bates G., Harper P., and Jones L. (Eds). Huntington's disease. 3rd edition (2002), Oxford University Press, Oxford 62-95
18. de Zubicaray G.I., Andrew C., Zelaya F.O., Williamsn S.C.R., and Dumanoir C. Motor response suppression and the prepotent tendency to respond: A parametric fMRI study. Neuropsychologia 38 (2000) 1280-1291
19. Easdon C., Izenberg A., Armillio M.L., Yu H., and Alain C. Alcohol consumption impairs stimulus- and error-related processing during a Go/No-Go task. Brain Research Cognitive Brain Research 25 (2005) 973-993
20. Falkenstein M. Inhibition, conflict and the Nogo-N2. Clinical Neurophysiology 117 (2006) 1640
21. Falkenstein M., Hohnsbein J., Hoormann J., and Blanke L. Effects of crossmodal divided attention on the ERP components. II. Error processing in choice reaction tasks. Electroencephalography Clinical Neurophysiology 78 (1991) 447-455
22. Falkenstein M., Hoormann J., and Hohnsbein J. ERP components in Go/Nogo tasks and their relation to inhibition. Acta Psychologica-Amsterdam 101 (1999) 267-291
23. Falkenstein M., Hoormann J., and Hohnsbein J. Inhibition-related ERP components: Variation with modality, age, and time-on-task. Journal of Psychophysiology 16 (2002) 167-175
24. Fallgatter A.J., and Muller T.J. Electrophysiological signs of reduced prefrontal response control in schizophrenic patients. Psychiatry Research 107 (2001) 19-28
25. Fallgatter A.J., Wiesbeck G.A., Weijers H.G., Boening J., and Strik W.K. Event-related correlates of response suppression as indicators of novelty seeking in alcoholics. Alcohol and Alcoholism 33 (1998) 475-481
26. Fallgatter A.J., Bartsch A.J., Zielasek J., and Herrmann M.J. Brain electrical dysfunction of the anterior cingulate in schizophrenic patients. Psychiatry Research 124 (2003) 37-48
27. Fallgatter A.J., Ehlis A.C., Seifert J., Strik W.K., Scheuerpflug P., Zillessen K.E., et al. Altered response control and anterior cingulate function in attention-deficit/hyperactivity disorder boys. Clinical Neurophysiology 115 (2004) 973-981
28. Fielding J., Georgiou-Karistianis N., Bradshaw J., Millist L., Churchyard A., and White O. Accelerated time-course of inhibition of return in Huntington's disease. Behavioral Brain Research 166 (2006) 211-219
29. Finke K., Bublak P., Dose M., Müller H.J., and Schneider W.X. Parameter-based assessment of spatial and non-spatial attentional deficits in Huntington's disease. Brain 129 (2006) 1137-1151
30. Garavan H., Ross T.J., Murphy K., Roche R.A., and Stein E.A. Dissociable executive functions in the dynamic control of behavior: Inhibition, error detection, and error correction. Neurimage 17 (2002) 1820-1829
31. Gehring W.J., Goss B., Coles M.G.H., Meyer D.E., and Donchin E. A neural system for error detection and compensation. Psychological Science 4 (1993) 385-390
32. Ginovart N., Lundin A., Farde L., Halldin C., Backman L., Pauli S., et al. PET study of the pre- and post-synaptic dopaminergic markers for the neurodegenerative process in Huntington's disease. Brain 120 (1997) 503-514
33. Gratton G., Coles M.G., and Donchin E. A new method for off-line removal of ocular artifact. Electroencephalogr. Clinical Neurophysiology 55 (1983) 468-484
34. Greenblatt R.E., Ossadtchi A., and Pflieger M.E. Local linear estimators for the bioelectromagnetic inverse problem. IEEE Transactions on Signal Processing 53 (2005) 3403-3412
35. Gutekunst C.A., Norflus F., and Hersch S.M. The neuropathology of Huntington's disease. In: Bates G., Harper P., and Jones L. (Eds). Huntington's disease. 3rd edition (2002), Oxford University Press, Oxford 251-276
36. Heinsen H., Strik M., Bauer M., Luther K., Ulmar G., Gangnus D., et al. Cortical and striatal neurone number in Huntington's disease. Acta Neuropathologica-Berlin 88 (1994) 320-333
37. Hester R., and Garavan H. Executive dysfunction in cocaine addiction: evidence for discordant frontal, cingulate, and cerebellar activity. Journal of Neuroscience 24 (2004) 11017-11022
38. Holmes A.P., Blair R.C., Watson J.D.G., and Ford I. Non-parametric analysis of statistic images from functional mapping experiments. Journal of Cerebral Blood Flow and Metabolism 16 (1996) 7-22
39. Hucho F. The neurochemistry of Parkinson's disease-comments on present and future developments. Journal of Neural Transmission Supplement 46 (1995) 59-65
40. Huntington Study Group. Unified Huntington's disease rating scale: Reliability and consistency. Movement Disorders 11 (1996) 136-142
41. Huntingtons Disease Collaborative Research Group. A novel gene containing a trinucleotide repeat that is expanded and unstable in Huntington's disease chromosomes. Cell 72 (1993) 971-983
42. Konishi S., Nakajima K., Uchida I., Sekihara K., and Miyashita Y. NoGo dominant brain activity in human inferior prefrontal cortex revealed by functional magnetic resonance imaging. European Journal of Neuroscience 10 (1998) 1209-1213
43. Kosslyn S.M., and Koening O. Wet mind: The New Cognitive Neuroscience (1992), Free Press
44. Lantz G., Grave de Peralta R., Spinelli L., Seeck M., and Michel C.M. Epileptic source localization with high density EEG: How many electrodes are needed?. Clinical Neurophysiology 114 (2003) 63-69
45. Lawrence A.D., Hodges J.R., Rosser A.E., Kershaw A., ffrench-Constant C., Rubinsztein D.C., et al. Evidence for specific cognitive deficits in preclinical Huntington's disease. Brain 121 (1998) 1329-1341
46. Marco-Pallares J., Grau C., and Ruffini G. Combined ICA-LORETA analysis of mismatch negativity. Neuroimage 25 (2005) 471-477
47. Mathalon D.H., Whitfield S.L., and Ford J.M. Anatomy of an error: ERP and fMRI. Biological Psychology 64 (2003) 119-141
48. Menon V., Adleman N.E., White C.D., Glover G.H., and Reiss A.L. Error-related brain activation during a Go/NoGo response inhibition task. Human Brain Mapping 12 (2001) 131-143
49. Menon V., Leroux J., White C.D., and Reiss A.L. Frontostriatal deficits in fragile X syndrome: Relation to FMR1 gene expression. Proceedings of the National Academy of Sciences USA, vol.101 (2004) 3615-3620
50. Mitchell I.J., Cooper A.J., and Griffiths M.R. The selective vulnerability of striatopallidal neurons. Progress in Neurobiology 59 (1999) 691-719
51. Naito E., and Matsumura M. Movement-related potentials associated with motor inhibition under different preparatory states during performance of two visual signal paradigms in humans. Neuropsychologia 34 (1996) 565-573
52. Nieuwenhuis S., Yeung N., van den Wildenberg W., and Ridderinkhof K.R. Electrophysiological correlates of anterior cingulate function in a Go/No-Go task: Effects of response conflict and trial type frequency. Cognitive Affective and Behavioral Neuroscience 3 (2003) 17-26
53. Pascual-Marqui R.D. Standardized low-resolution brain electromagnetic tomography (sLORETA): Technical details. Methods and Findings in Clinical Pharmacology 24 Suppl D (2002) 5-12
54. Pascual-Marqui R.D., Lehmann D., Koenig T., Kochi K., Merlo M.C., Hell D., et al. Low resolution brain electromagnetic tomography (LORETA) functional imaging in acute, neuroleptic-naïve, first-episode, productive schizophrenia. Psychiatry Research 90 (1999) 169-179
55. Pavese N., Andrews T.C., Brooks D.J., Ho A.K., Rosser A.E., Barker R.A., et al. Progressive striatal and cortical dopamine receptor dysfunction in Huntington's disease: A PET study. Brain 126 (2003) 1127-1135
56. Petersen A., Larsen K.E., Behr G.G., Romero N., Przedborski S., Brundin P., et al. Expanded CAG repeats in exon 1 of the Huntington's disease gene stimulate dopamine-mediated striatal neuron autophagy and degeneration. Human Molecular Genetics 10 (2001) 1242-1254
57. n repeats in parent-offspring pairs with Huntington's disease. American Journal of Human Genetics 57 (1995) 593-602
58. Reading S.A., Dziorny A.C., Peroutka L.A., Schreiber M., Gourley L.M., Yallapragada V., et al. Functional brain changes in presymptomatic Huntington's disease. Annals of Neurology 55 (2004) 879-883
59. Redgrave P., Prescott T.J., and Gurney K. The basal ganglia: A vertebrate solution of the selection problem?. Neuroscience 89 (1999) 1009-1023
60. Ridderinkhof K.R., van den Wildenberg W.P., Segalowitz S.J., and Carter C.S. Neurocognitive mechanisms of cognitive control: the role of prefrontal cortex in action selection, response selection, response inhibition, performance monitoring, and reward-based learning. Brain and Cognition 56 (2004) 129-140
61. Roche R.A., Garavan H., Foxe J.J., and ÓMara S.M. Individual differences discriminate event-related potentials but not performance during response inhibition. Experimental Brain Research 160 (2005) 60-70
62. Rosas H.D., Feigin A.S., and Hersch S.M. Using advances in neuroimaging to detect, understand, and monitor disease progression in Huntington's disease. NeuroRx 1 (2004) 263-272
63. Sekihara K., Sahani M., and Nagarajan S.S. Localization bias and spatial resolution of adaptive and non-adaptive spatial filters for MEG source reconstruction. Neuroimage 25 (2005) 1056-1067
64. Slotnik S.D. Source localization of ERP generators. In: Handy T.C. (Ed). Event-related potentials. A methods handbook (2005), MIT Press
65. Snowden J.S., Craufurd D., Thompson J., and Neary D. Psychomotor, executive, and memory function in preclinical Huntington's disease. Journal of Clinical and Experimental Neuropsychology 24 (2002) 133-145
66. van Dellen A., Deacon R., York D., Blakemore C., and Hannan A.J. Anterior cingulate cortical transplantation in transgenic Huntington's disease mice. Brain Research Bulletin 56 (2001) 313-318
67. van den Wildenberg W.P., van Boxtel G.J., van der Molen M.W., Bosch D.A., Speelman J.D., and Brunia C.H. Stimulation of the subthalamic region facilitates the selection and inhibition of motor responses in Parkinson's disease. Journal of Cognitive Neuroscience 18 (2006) 626-636
68. van Oostrom J.C., Maqzire R.P., Verschuuren-Bemelmans C.C., Veenma-van der Duin L., Pruim J., Roos R.A., et al. Striatal dopamine D2 receptors, metabolism, and volume in preclinical Huntington's disease. Neurology 65 (2005) 941-943
69. van Veen V., and Carter C.S. The anterior cingulate as a conflict monitor: fMRI and ERP studies. Physiology and Behavior 77 (2002) 477-482
70. Verleger R., Paehge T., Kolev V., l Yordanova J., and Jaskowski P. On the relation of movement-related potentials to the Go/No-go effect on P3. Biological Psychology 73 (2006) 298-313
71. Weissman D.H., Warner L.M., and Woldorff M.G. The neural mechanisms for minimizing cross-modal distraction. Journal of Neuroscience 24 (2004) 10941-10949